Publications by authors named "Jinalben Patel"

Claim this Profile
C
Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: A CIBMTR Analysis.
Kalyan V Nadiminti, Kwang W Ahn, Jinalben Patel, Qinghua Lian, Evandro Bezerra

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19 directed CAR T therapy for intravascular large B-cell lymphoma.
Jinalben Patel, Ajay Gopal, Hannah Cherniawsky, Ron Ram, Rammurti Kamble

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19 Directed CAR T Therapy for Transformed Follicular Lymphoma: A CIBMTR Analysis.
Swetha Kambhampati Thiruvengadam, Kwang Woo Ahn, Jinalben Patel, Qinghua Lian, Mark Hertzberg

Am J Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis.
Jordan Gauthier, Kwang W Ahn, Jinalben Patel, Qinghua Lian, Sherif Badawy

Am J Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS.
Nasheed M Hossain, Kwang Woo Ahn, Jinalben Patel, Qinghua Lian, Muhammad Bilal Abid

Br J Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis.
Miguel-Angel Perales, Farrukh T Awan, Ariane Boumendil, Jinalben Patel, Luca Castagna

Blood· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-Cell Lymphoma Patients in Remission After Salvage Treatments.
Fateeha Furqan, Kwang W Ahn, Manmeet Kaur, Jinalben Patel, Stephen Ansell

Am J Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of older adults and frail patients receiving idecabtagene vicleucel: a CIBMTR study.
Othman Salim Akhtar, Temitope Oloyede, Ruta Brazauskas, Aimaz Afrough, Hamza Hashmi, Jinalben Patel, Krina Patel

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haploidentical, matched-related, and matched-unrelated hematopoietic cell transplant for acute leukemias in the early years of haploidentical transplant implementation in a developing country with a large unrelated donor registry.
Adriana Seber, Leonardo Javier Arcuri, Vergilio Rensi Colturato, Mair Pedro Souza, Yana Augusta Novis Zogbi, Jinalben Patel

Front Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Hematopoietic Cell Transplant for Hematologic Cancers by Race, Ethnicity, and Age.
Theresa Hahn, Megan M Herr, Ruta Brazauskas, Jinalben Patel, Sikander Ailawadhi

JAMA Netw Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities.
Nandita Khera, Sikander Ailawadhi, Ruta Brazauskas, Jinalben Patel, Benjamin Jacobs

Blood Adv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis.
Brandon J Blue, Ruta Brazauskas, Karen Chen, Jinalben Patel, Amer M Zeidan

Transplant Cell Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis